Tag: Moderna

Moderna Inc. has resolved a multi-year legal dispute concerning its foundational mRNA technology, removing a significant overhang that has weighed ...

As of February 2026, the two biotech pioneers synonymous with the mRNA-based COVID-19 vaccine rollout, Moderna and BioNTech, face a ...

Biotechnology firm Moderna is navigating one of the most challenging periods in its corporate history, implementing sweeping changes to secure ...

As Moderna navigates its challenging transition beyond pandemic-era vaccine dominance, the biotechnology firm has secured overwhelming shareholder approval for a ...

Today represents a watershed moment for biotechnology firm Moderna as it prepares to release quarterly results that will signal whether ...

Moderna shares experienced a dramatic upswing following reports of potential acquisition talks or a major strategic partnership, breaking a prolonged ...

The pharmaceutical company Moderna, once celebrated for its COVID-19 vaccine success, is now confronting a severe crisis of investor confidence. ...

Moderna, the pioneering vaccine developer, may be on the verge of its most significant achievement since its COVID-19 vaccine success. ...

Wednesday delivered an unexpected boost for Moderna as the biotechnology firm's stock surged more than 6%, marking a dramatic reversal ...

Moderna shares experienced a notable downturn this week, declining nearly 5% on Thursday to close at approximately €21. This sell-off ...